Ocrelizumab (Anti-CD20)

目录号：A2561         批次号: A256102

打印

Ocrelizumab (Anti-CD20)是一种重组人源化单克隆 IgG1 抗体，选择性靶向 B 细胞上存在的 CD20 抗原。它用于治疗复发缓解型多发性硬化症。分子量：145.5 KD。

抗体信息

CAS号 637334-45-3
配制 100 mM Pro-Ac, 20mM Arg, pH5.0
推荐同型对照 Human IgG1
来源 CHO
储存条件
(自收到货起)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
除菌 0.2 μM filtered
纯度 99%
蛋白浓度 8.595mg/ml
内毒素 ＜1EU/mg

Ocrelizumab (Anti-CD20)在文献中得到引用

An approach for single-amino-acid resolution epitope mapping by kinetic affinity screening of antibody drugs against biosensor on-chip library of deep mutationally-scanned target variants [ bioRxiv, May 05, 2026, Not applicable] PubMed: 42146546

禁止用于人体及治疗！